(Q44658205)

5 December 2017

title

Hippocampal N-acetyl aspartate levels do not mirror neuronal cell densities in creatine-supplemented epileptic rats (English)

1 reference

5 December 2017

6

1 reference

5 December 2017

10

1 reference

5 December 2017

Stefan Vielhaber

1

1 reference

5 December 2017

Alexei P Kudin

2

1 reference

5 December 2017

Tatiana A Kudina

3

1 reference

5 December 2017

Detlef Stiller

4

1 reference

5 December 2017

Henning Scheich

5

1 reference

5 December 2017

Helmut Feistner

7

1 reference

5 December 2017

Hans-Jochen Heinze

8

1 reference

5 December 2017

Christian E Elger

9

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

European Journal of Neuroscience

5 December 2017

published in

1 reference

5 December 2017

volume

18

1 reference

5 December 2017

issue

8

1 reference

5 December 2017

page(s)

2292-2300

1 reference

Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Evidence supporting a role for N-acetyl-l-aspartate as a molecular water pump in myelinated neurons in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Cell death and synaptic reorganizations produced by seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

On the mechanisms of neuroprotection by creatine and phosphocreatine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Age-dependent consequences of seizures and the development of temporal lobe epilepsy in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Quantitative 1H MRS in the evaluation of mesial temporal lobe epilepsy in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

N-acetylaspartate as an in vivo marker of neuronal viability in kainate-induced status epilepticus: 1H magnetic resonance spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Resistance of immature hippocampus to morphologic and physiologic alterations following status epilepticus or kindling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Creatine-supplemented diet extends Purkinje cell survival in spinocerebellar ataxia type 1 transgenic mice but does not prevent the ataxic phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Comparative diagnostic utility of 1H MRS and DWI in evaluation of temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

A placebo-controlled crossover trial of creatine in mitochondrial diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Seizure-dependent modulation of mitochondrial oxidative phosphorylation in rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Proton spectroscopic imaging at 4.1 tesla in patients with malformations of cortical development and epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Fluorescent tracer in pilocarpine-treated rats shows widespread aberrant hippocampal neuronal connectivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Proton MRS of oral creatine supplementation in rats. Cerebral metabolite concentrations and ischemic challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Synthesis of N-acetyl-l-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Neuronal and glial metabolite content of the epileptogenic human hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Epileptogenesis after status epilepticus reflects age- and model-dependent plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

A simplified timm stain procedure compatible with formaldehyde fixation and routine paraffin embedding of rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Temporal lobectomy for epilepsy: recovery of the contralateral hippocampus measured by (1)H MRS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Effect of creatine supplementation on metabolite levels in ALS motor cortices

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Novel mitochondrial creatine transport activity. Implications for intracellular creatine compartments and bioenergetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Evaluation of methods for the determination of mitochondrial respiratory chain enzyme activities in human skeletal muscle samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Temporal profile of neuronal injury following pilocarpine or kainic acid-induced status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

Magnetic resonance spectroscopic imaging in temporal lobe epilepsy: neuronal dysfunction or cell loss?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2003.02954.X

10.1046/J.1460-9568.2003.02954.X

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference